SR0608LRB100 13129 MST 27519 r

1
SENATE RESOLUTION

 
2    WHEREAS, Cystinuria occurs in individuals in which a rare
3genetic defect prevents the body from regulating amino acid
4concentrations, subsequently leading to elevated levels of
5cystine and the formation of cystine stones in the kidney,
6ureter, and bladder; and
 
7    WHEREAS, The American Urological Association recognizes
8Cystinuria as the most common monogenic kidney stone disorder;
9and
 
10    WHEREAS, The majority of Cystinuria patients start to
11suffer from chronic cystine stone formation before the age of
1220; and
 
13    WHEREAS, Cystinuria patients often endure episodes of
14debilitating pain (typically known as renal colic), nausea,
15vomiting, and recurrent urinary tract infections; and
 
16    WHEREAS, The majority of Cystinuria patients will require
17numerous stone removal procedures and surgeries; and
 
18    WHEREAS, Studies have demonstrated Cystinuria patients
19have worse health related quality of life than the general
20population, specifically in areas of general health, bodily

 

 

SR0608- 2 -LRB100 13129 MST 27519 r

1pain, and mental health; and
 
2    WHEREAS, Cystinuria patients may suffer from life
3threatening complications, such as hypertension, renal
4insufficiency, end stage renal disease, and the need for a
5kidney transplant; and
 
6    WHEREAS, The majority of Cystinuria patients forming
7recurrent stones will develop some form of chronic kidney
8disease in their lifetime; and
 
9    WHEREAS, There is no cure for Cystinuria, treatment options
10significantly reduce medically necessary surgeries and some
11patients can live a stone-free life; and
 
12    WHEREAS, Cystinuria can be diagnosed from analysis of a
1324-hour urine test; and
 
14    WHEREAS, Detection may be improved by increased education
15and screening, as many patients do not receive a diagnosis
16until after enduring one or more stone episodes; and
 
17    WHEREAS, Early diagnosis is important to the long-term
18management of a Cystinuria, which can potentially limit
19permanent kidney damage and persevere maximal kidney function;
20and
 

 

 

SR0608- 3 -LRB100 13129 MST 27519 r

1    WHEREAS, One in every 10,000 Americans are believed to be
2genetically at risk for Cystinuria; and
 
3    WHEREAS, Cystinuria has been documented as a leading risk
4factor for one of the top most common forms of kidney stones;
5and
 
6    WHEREAS, Kidney stone experts cite the economic burden in
7the United States for providing care for individuals, of
8working age, with kidney stones to be $5.3 billion dollars in
9the year 2000; and
 
10    WHEREAS, Doctors at Southern Illinois University's School
11of Medicine have world-leading expertise on Cystinuria; and
 
12    WHEREAS, Well-supported research funding for Cystinuria
13will lead to improved screening and treatment, improved quality
14of life, and expedite the development of a cure; therefore, be
15it
 
16    RESOLVED, BY THE SENATE OF THE ONE HUNDREDTH GENERAL
17ASSEMBLY OF THE STATE OF ILLINOIS, that we recognize June 24,
182017 as "National Cystinuria Awareness Day" to promote
19awareness of Cystinuria and show support for research at the
20Illinois medical research centers that take an active role in

 

 

SR0608- 4 -LRB100 13129 MST 27519 r

1the fight against Cystinuria.